Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim Biosimilar vs Granulokine in Chemotherapy-Induced Neutropenia
NCT01079676Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Mar 2011
- Primary completion
- Apr 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of filgrastim in neutropenia, sponsored by Eurofarma. Started Mar 2011; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01079676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01079676.